Table 2.

Values of routine analytes and of amino acids or biogenic amines and their derivatives.

	Fontan patients	Controls	P-value
Hematocrit [%]	47.8 ± 5.6	39.3 ± 4.2	<0.00001↑
Hemoglobin [g/dL]	16.4 ± 2.1	12.7 ± 1.4	<0.00001↑
Total cholesterol [mg/dL]	145.3 ± 26.5	149 ± 34.2	0.77
HDL-C [mg/dL]	42.5 ± 15.9	51.3 ± 12.3	0.03↓
Non-HDL-C [mg/dL]	85.2 ± 24.8	73.1 ± 20.8	0.2
Triglycerides [mg/dL]	128.6 ± 86.5	47.3 ± 22.8	0.003↑
Total protein [g/dL]	7.2 ± 0.5	7.0 ± 0.7	0.31
Albumin [mg/dL]	4145 ± 492	4215 ± 208	0.64
Creatinine [mg/dL]	0.8 ± 0.12	0.53 ± 0.18	<0.00001↑
Total bilirubin [mg/dL]	1.22 ± 0.67	0.3 ± 0.29	<0.00001↑
AST [U/L]	35.3 ± 7.7	31.6 ± 8.4	0.12
ALT [U/L]	39.4 ± 11.4	31.9 ± 10.1	0.04↑
gGT [U/L]	86.5 ± 43.6	35.1 ± 19.4	0.00002↑
INR	2.1 ± 0.76	1.02 ± 0.04	<0.00001↑
NT-proBNP [pg/mL]	52.4 ± 69.2	39.3 ± 30.4	0.88
CRP [mg/dL]	0.18 ± 0.2	0.16 ± 0.14	0.47

Values are given as mean ± standard deviation. ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C-reactive protein; dL, decilitre; g, gram; gGT, gamma glutamyl transferase; HDL-C, high density lipoprotein-cholesterol; INR, international normalized ratio; NT-proBNP, N-terminal prohormone of brain natriuretic peptide; U, unit; ↑, statistically significant higher serum concentration in Fontan patients than in controls; ↓, statistically significant lower serum concentration in Fontan patients than in controls.